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Global healtha b s t r a c t
Dog-rabies elimination programs have typically relied upon parenteral vaccination at central-point loca-
tions; however, dog-ownership practices, accessibility to hard-to-reach sub-populations, resource limita-
tions, and logistics may impact a country’s ability to reach the 70% coverage goal recommended by the
World Organization for Animal Health (OIE) and World Health Organization (WHO). Here we report the
cost-effectiveness of different dog-vaccination strategies during a dog-rabies outbreak in urban and peri-
urban sections of Croix-des-Bouquets commune of the West Department, Haiti, in 2016. Three strategies,
mobile static point (MSP), mobile static point with capture-vaccinate-release (MSP + CVR), and door-to-
door vaccination with oral vaccination (DDV + ORV), were applied at five randomly assigned sites and
assessed for free-roaming dog vaccination coverage and total population coverage. A total of 7065 dogs
were vaccinated against rabies during the vaccination campaign. Overall, free-roaming dog vaccination
coverage was estimated at 52% (47%-56%) for MSP, 53% (47%-60%) for DDV + ORV, and 65% (61%-69%)
for MSP + CVR (differences with MSP and DDV + ORV significant at p < 0.01). Total dog vaccination cover-
age was 33% (95% CI: 26%-43%) for MSP, 49% (95% CI: 40%-61%) for MSP + CVR and 78% (77%-80%) for DDV
+ ORV (differences significant at p < 0.001). Overall, the least expensive campaign was MSP, with an esti-
mated cost of about $2039 per day ($4078 total), and the most expensive was DDV + ORV with a cost of
$3246 per day ($6492 total). Despite the relative high cost of an ORV bait, combining DDV and ORV was
themost cost-effective strategy in our study ($1.97 per vaccinated dog), largely due to increased efficiency
of the vaccinators to target less accessible dogs. Costs per vaccinated dog were $2.20 for MSP and $2.28 for
MSP + CVR. We hope the results from this study will support the design and implementation of effective
dog vaccination campaigns to achieve the goal of eliminating dog-mediated human rabies deaths by 2030.
 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction is responsible for an estimated 59,000 human deaths annually,Rabies is among the most lethal infectious diseases with the
highest case fatality rate of etiological agents. Worldwide, rabies99% of which are due to a bite of an infected domestic dog [1–
3]. Thus, controlling rabies in dog populations substantially




6163 E.A. Undurraga et al. / Vaccine 38 (2020) 6162–6173cessfully eliminated in most of the Western Hemisphere, Europe,
and some countries in Asia. These success stories have been
focused on routine, annual campaigns of mass dog vaccination as
the primary intervention, requiring coordination and engagement
at the national and community levels [4–9]. The World Health
Organization (WHO) and World Organization for Animal Health
(OIE) recommend dog-rabies endemic countries to conduct recur-
rent mass vaccination campaigns covering  70% of the dog popu-
lation, sustained over three to seven years, to control and
potentially eliminate dog rabies [1,10,11].
Dog-rabies elimination programs have typically relied upon
parenteral vaccination at mobile static points (MSP); however,
dog-ownership practices, ability to vaccinate hard-to-reach sub-
populations, resource limitations, and logistics may impact a coun-
try’s ability to reach the 70% goal in many settings [12,13]. Door-
to-door vaccination (DDV) and capture-vaccinate-release (CVR)
strategies have also been used in various settings to reach a larger
dog population, including aggressive or overly shy dogs, but are
more labor-intensive than MSP, and require special training
[14,15]. Oral rabies vaccination (ORV) baits have been approved
for use in wildlife as a compliment to parental vaccination of
domestic animals [16–18], and have been used to vaccinate free-
roaming dogs in various settings, but the technology is still under
development [19,20] (Table 1). Dog-rabies endemic countries are
at different stages of their rabies control capacity, and may faceTable 1







Community members are encouraged, through community
engagement activities, to bring dogs to a centralized location w
vaccinators have established a temporary vaccination clinic
Owned dogs and dogs which are always or partially confined t





Vaccinators are required to capture the dog before vaccination




Vaccinators visit each household to offer dog vaccination
Do not require owner to bring dog to a MSP clinic




Baits are handed to a dog or placed in the community for dogs to
Do not require dog restraint
May more readily reach aggressive and shy dogs
May reach free roamingy, community owned and stray dogs
Notes: The three vaccination strategies we assessed, combined the methods defined in th
vaccination is the standard vaccine type, globally, with many different vaccines being pr
dogs. Parenteral vaccines are produced by inactivating rabies virus constructs [37].
y Free roaming dogs constitute the highest rabies-risk population and largest contributo
 CVR should only be conducted under conditions which utilize humane methods and e
§Several ORV baits have been approved for use in wildlife in the United States and intern
programs in regards to domesticated animals [16–18]. Oral vaccines have also been usesubstantial challenges including, for example, a limited under-
standing of local epidemiology, inadequate financial and human
resources, competing priorities of other diseases, and planning
and logistic constraints [21–24]; one such country is the Republic
of Haiti [22,25].
Haiti has the highest human rabies burden in the Western
Hemisphere [22,25–27], though the true prevalence and incidence
of rabies remain unknown. An annual average of four canine rabies
cases and seven human rabies cases were reported in Haiti in
2010–2012 [26,28]. However, as in other countries [1-4,21,29–
31], many human and dog rabies cases in Haiti are not recognized
and/or reported to health authorities [22], limiting awareness,
funding, and prevention efforts. For example, an 18-fold increase
in case detection was reported following implementation of an ani-
mal rabies surveillance system in Haiti from 2013 to 2015 [22]. A
modeling effort to assess the global burden of rabies estimated
about 130 annual deaths from rabies in Haiti [2]. Resource limita-
tions and competing health priorities have resulted in inadequate
surveillance and laboratory capacity and few trained health profes-
sionals [22,28,32]. In collaboration with the US Centers for Disease
Control and Prevention (CDC) and other agencies, the Haitian gov-
ernment has developed several initiatives to prevent and control
dog rabies, including integrated bite case management, enhanced
surveillance methods and expansion of mass dog vaccination cam-
paigns [22,25,32–34]. Despite important improvements in rabiesLimitations
here
Free roaming dogsy may not be readily handled by dog owners, thus




Community owned and stray dogs typically have no person or family
which feels responsibility to bring these dogs to a MSP clinic
Parenteral rabies vaccine, requires dog restraint with potential risk of
bites
Aggressive or overly shy dogs less likely to be brought to a MSP
Depend on owner awareness of MSP clinic, and geographical
accessibility
Requires a skilled workforce to capture and vaccinate dogs in a safe
manner for the animal and vaccinator, may decrease effectiveness in
time due to dogs running away from vaccinators.
Parenteral rabies vaccine, requires dog restraint with potential risk of
bites
More labor-intensive than MSP
Free-roaming dogs and/or owner may not be at home when the
vaccinators arrive
Parenteral rabies vaccine, requires dog restraint with potential risk of
bites
Unlikely to reach community owned and stray dogs
ingest Technology still under development, limited field data on
implementation
Vaccines are more costly than parental vaccines
Oral rabies vaccines are based on live replication competent viruses
e table: (1) MSP, (2) MSP + CVR, DDV + ORV. * Parenteral rabies vaccine. Parenteral
oduced and approved by the World Organization for Animal Health (OIE) for use in
rs of enzootic rabies transmission.
quipment that ensure the safety of both the animal and the vaccinator.
ationally, and have shown to be a successful compliment to parenteral vaccination
d to vaccinate free-roaming dogs in various settings [19,20].
6164 E.A. Undurraga et al. / Vaccine 38 (2020) 6162–6173control, mass dog vaccination campaigns in Haiti have not yet
reached the frequency and intensity required for rabies elimination
[32,35].
Vaccination campaigns in Haiti frequently use a MSP strategy,
but national coverage rates have never reached a 50% coverage
and rabies cases continue to occur. To increase dog vaccination
coverage, several community awareness events are conducted dur-
ing the week before the vaccination campaign. On the day of the
campaign, vaccinators set up fixed vaccination stations to which
community members bring their dogs. Limited DDVmay also occur
if time allows and if not impeded by cultural norms. A recent eval-
uation of the 2015 campaign estimated that about 36%, 61%, and
50% of free-roaming dogs were vaccinated in urban, semi-urban,
and rural communities, respectively [36]. The study found approx-
imately 83% of Haitian dogs are allowed to roam freely in the com-
munity for at least part of their day, and up to 44% of dogs may be
community owned.1 Free roaming and community owned dogs are
typically harder to reach for rabies vaccination through MSP, which
require a person to physically bring the dog to the vaccination site
[35]. These findings, and the fact that despite several years of animal
rabies vaccination campaigns using MSP there has been no notice-
able decrease in animal rabies cases [27], suggest that MSP vaccina-
tion alone may not be sufficient to achieve herd immunity for rabies
control. In August 2016 a rabies outbreak was detected through Hai-
ti’s national rabies surveillance program, with seven dog rabies cases
confirmed in the commune of Croix-des-Bouquet. In response, the
Haitian government, CDC, and other organizations conducted an
emergency vaccination program using three dog vaccination strate-
gies in addition to MSP: DDV, CVR, and a modified live ORV [37].
Here we report the results from an evaluation of costs, effective-
ness, and cost-effectiveness outcomes for three alternative combi-
nations of dog vaccination strategies in urban and peri-urban
sections of Croix-des-Bouquet commune, West Department, Haiti,
in 2016, during a dog rabies outbreak. We present results as cost-
per-dog-vaccinated, using a governmental perspective. Results are
intended to help inform policy-makers about ways to improve dog
vaccination coverage under budget constraints, and support the
planning of more effective dog vaccination campaigns, with the
ultimate goal of controlling and potentially eliminating dog-
mediated human rabies deaths [23].2. Materials and methods
2.1. Study area
The outbreak area of Croix-des-Bouquets was divided into five
zones of approximately equivalent human population size
(20,000 people per zone), based on data from the Institut Haitien
de Statistique et d’Informatique (IHSI) [38]. Zones were classified
as peri-urban (human population density < 300 per km2) or urban
(>300 people per km2). Each zone was further divided into three
evaluation sites of equivalent human population (6500 people).
Using an estimated human-to-dog ratio of 10, each planning vacci-
nation site had an estimated 650 dogs. We established a vaccina-
tion goal of at least 450 dogs per site, to achieve OIE/WHO’s
recommended goal of vaccinating  70% of the dog population
[1,10,11]. The vaccination method was assigned randomly to three
evaluation sites within each of the five zones (Fig. 1), and the cam-
paign was conducted in August 2016. Further details about the1 Community owned dogs typically receive food and other resources from multiple
families. Community owned dogs are at a higher risk for rabies because they spend
more time on the streets interacting with other dogs, and because there are typically
few people who feel responsible for the community dogs’ veterinary care.campaign design and implementation are shown in the supple-
mentary material.
2.2. Vaccination strategies
Table 1 describes each vaccination strategy. Vaccination was
scheduled for working two days in each strategy, at the five vacci-
nation sites. Sensitization of the community was conducted in the
week prior to vaccination at all sites. All vaccination teams used a
standardized paper form to track the number of dogs vaccinated
per hour, hours worked per day, and other logistical data (supple-
mentary material). We assigned a color to each vaccination strat-
egy, and all vaccinated dogs received a temporary plastic collar
and wax mark representing the strategy by which they were vac-
cinated [36]. Vaccination teams operated for two days in each site.
The teams worked for up to six hours daily to vaccinate dogs at
each evaluation site and were paid a fixed daily rate, even if there
were no more dogs to be vaccinated at the assigned site. On days
three and four (the two days after the vaccination site was com-
pleted) a sight-resight evaluation was conducted to determine
the dog population, demography, and free-roaming dog vaccina-
tion coverage. The three vaccination strategies were:
(1) MSP. Four vaccinators with at least two years of experience
and four assistants carried out routine parenteral vaccination. Vac-
cinators used a banner and megaphones to announce their pres-
ence, and used yellow collars and yellow wax to mark vaccinated
dogs. Vaccinators remained at one location for one to two hours
and moved another central location when community members
were no longer bringing their dogs to vaccinate (Fig. 2A). MSP sites
were pre-selected and exact locations for the MSP clinic were cho-
sen by staff and local leaders on the morning of the campaign.
(2) MSP plus CVR. In addition to the MSP strategy, three teams
of two trained health personnel (vaccinator and assistant), con-
ducted CVR of free-roaming dogs. CVR vaccinators were members
of Haiti’s Animal Rabies Surveillance Program, which routinely
captures suspected rabid dogs (Fig. 2B). Tools used included pole
nets, control poles, Kevlar gloves, in addition to the supplies pro-
vided to MSP teams. MSP teams used blue collars and blue wax
to identify vaccinated dogs and CVR teams used pink collars and
pink wax to identify vaccinated dogs. CVR teams walked through
pre-defined sites and announced their presence through mega-
phones as they walked through the community.
(3) DDV plus ORV. Five teams of two trained personnel (vacci-
nator and assistant), conducted DDV/ORV. These sites included
no MSP. Vaccination teams walked through pre-defined sites and
announced their presence through megaphones and by approach-
ing domiciles. When possible, dogs were vaccinated parenterally;
aggressive, scared, or dogs with no identifiable owner, were offered
an ORV bait. Dogs were observed until they ate the ORV bait or lost
interest in it. Every attempt was made to recover the foil/plastic
vaccine capsule. Parenterally vaccinated dogs received white col-
lars and white wax; dogs vaccinated by ORV received purple col-
lars and purple wax or temporary purple paint sprayed from a
20 ml syringe, depending on how approachable the dog was.
Almost no dogs with ORV received a collar, and it was not always
possible to mark ORV dogs. We used boiled pig intestines as coat-
ing for the oral vaccines [37] (Fig. 2C).
2.3. Dog population
Three dog population categories were defined 1) owned, con-
fined 2) owned, sometimes free-roaming 3) community owned,
always free-roaming. We estimated the dog population for each
site by adding the estimated number of owned, confined dogs from
household surveys to our estimate of free-roaming dogs. To derive
Fig. 1. Location of the dog rabies vaccination intervention and study design for the evaluation of alternative dog vaccination strategies to improve dog population coverage,
Croix-des-Bouquets, West Department, Haiti 2016. Notes. MSP: mobile static point. CVR: capture, vaccinate, release. DDV: door to door vaccination. ORV: oral rabies
vaccination. Study area in the West Department, Haiti. The focal outbreak area of Croix-des-Bouquets was divided into five zones of approximately equivalent human
population size (20,000 people per zone). One DDV-ORV site did not receive ORV and was excluded from analyses. Each of the five zones was divided into three sites, and we
randomly assigned one vaccination strategy to each of these sites.
Fig. 2. Rabies vaccination strategies. A. In the mobile static point strategy, community members bring dogs to a centralized location where vaccinators have established a
temporary vaccination clinic. B. A trained rabies control officer captures a free-roaming dog in the capture-vaccinate-release strategy, which requires dog restraint with
potential risk of bites. C. Boiled pig intestines were used as coating for the oral vaccines, after piloting other alternatives. Dogs were observed until they ate the ORV bait or
lost interest in it. Aggressive, scared, or dogs with no identifiable owner, were offered an ORV bait when parenteral vaccination was not possible.
6165 E.A. Undurraga et al. / Vaccine 38 (2020) 6162–6173the number of free roaming dogs, we used the largest of two esti-
mates: the number of free-roaming dogs as determined by house-
hold surveys or as determined by field survey teams through sight-
resight (SRS) count surveys using the Lincoln-Petersen estimator[36,39]. Because almost all dogs had received temporary laminated
collars, wax marks, and/or spray paint (ORV) at the time of rabies
vaccination, we could also estimate vaccination coverage based
on the SRS survey. Detailed methods and results have been
6166 E.A. Undurraga et al. / Vaccine 38 (2020) 6162–6173described elsewhere [36]. We used Fisher’s exact mid-p test to
obtain 95% confidence intervals (CI) for each dog ownership
category.
2.4. Vaccination coverage and efficiency
We estimated dog vaccination coverage at each site for the free-
roaming and total dog populations, by vaccination strategy. Free-
roaming vaccination coverage was calculated directly from SRS
data. All dogs received temporary laminated collars, wax marks,
and/or spray paint at the time of rabies vaccination, and we used
a standardized data collection tool to estimate the proportion of
free roaming dogs with evidence of vaccination [36]. We evaluated
vaccination efficiency as the number of dogs vaccinated per staff
member per day. We used Fisher’s exact mid-p to obtain the 95%
CI; rates were compared by site, strategy, and urban and peri-
urban communities.Table 2
Cost data for the evaluation of alternative strategies for mass dog vacc
Item Unit v
Variable costs of dog vaccination
Vaccines
Vaccination certificates 0.10
Tag: dog collar 0.09
Tag: wax ID mark 0.05
Parenteral vaccinationv 0.58
Vaccine (parenteral vaccine) per dog 0.29
Material costs (needles, swabs, etc.) 0.04
Wasted / spoiled vaccines 2%
Oral vaccinationvǂ 2.55
Vaccine (oral vaccine) 2.00
Material costs (bait, etc.) per vaccine 0.20
Wasted / spoiled vaccines 5%
Fixed costs of dog vaccination (per site)*
Equipment/ supplies
Cold-boxes 40.00
Protective clothing / equipment (site) 90.00
Squirt gun 50.00
Ice packs 2.50
Hazardous waste management 4.00




Central point vaccinator y 9.00
Door-to-door vaccinator y 9.00




Vehicles (3 trucks for all sites) § 116.0
Gas (4 tanks per truck) 75.00
Awareness campaign
Truck with speakers 75.00
Driver 25.00
Pamphlets / posters 1.00
Notes: ID: identifier.
 Estimated from fieldwork.
v The unit costs for the parenteral and oral vaccination include the cos
Parenteral vaccines were donated, so we used a reference cost.
ǂ Based on an estimate not on fixed prices.
* Fixed costs were apportioned to daily fixed costs on the basis of a p
–Includes butterfly and throw nets, control supplies. We assumed th
equipment was required for all three campaigns strategies, although
y Central point vaccination was made of 4 groups of 2 persons each (on
consisted in three groups with three members each: a vaccinator, a he
to door had 5 teams of three members, a vaccinator, a helper, and a
§The trucks used were from MARNDR; to estimate daily costs per tru
the daily price for a truck rental in the study area.2.5. Productivity of vaccinators
We defined vaccination productivity in two ways: (A) dogs vac-
cinated per hour and (B) dogs vaccinated per vaccinator per hour
during the vaccination campaign. The relative vaccination produc-
tivity of each vaccination strategy varied throughout the day, with
marginal productivity declining for most strategies (i.e., there are
diminishing marginal returns over the hours). For example, for
MSP vaccination, many owned dogs are brought for vaccination
within the first several hours of vaccination clinic operations, but
available dogs wane as time goes by. We thus tracked the number
of vaccinated dogs per hour for each vaccination strategy.
To provide a measure of the productivity of each vaccination
strategy, we used ordinary least square (OLS) regressions with
robust standard errors. We used the two definitions of productivity
as our dependent variables. We used vaccination hours (range:
1–5 h) and vaccination strategy (MSP; MSP + CVR, and DDVination, West Department, Haiti 2016.
























ts of the vaccination certificate, and tags (dog collar and wax ID).
otential three-week campaign (15 work-days).
at they would last for two years. Animal capture and restraint
each CVR team required one equipment kit
e walking around with a megaphone). Capture-vaccinate-release
lper, and a data collector (excluded from costing estimates). Door
data collector (excluded from cost estimates).
ck (including depreciation, maintenance, and insurance) we used
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between vaccination strategy and time (supplementary material).
2.6. Cost data
We estimated the costs of each vaccination strategy using a
micro-costing approach, based on data from research budgets or
field expenditure reports. The major items included costs per vac-
cines by type, shipping, storage, cold-chain materials, and vaccine
transport, logistic support, personnel involved in each vaccination
strategy (including personnel qualifications, e.g., supervisors, vac-
cinators, and drivers), transport and per diem expenses of vaccina-
tion personnel, security equipment, employee pre-exposure
vaccinations, materials and supplies, hazardous waste manage-
ment, awareness/social mobilization campaigns, time required to
vaccinate each dog, marks/tags for vaccinated dogs, administra-
tion, and staff training. All costs are shown in 2016 US dollars.
Table 2 shows a summary of cost data. We excluded the costs asso-
ciated with data gathering and evaluation, including collection of
blood samples, as these costs would not be typically included in
a mass dog vaccination program.
We assumed that fixed costs of the vaccination campaign (i.e.,
costs that do not change as a function of the number of vaccina-
tions) were equally distributed between the three vaccination
strategies; daily fixed costs were apportioned on the basis of the
duration of the typical vaccination campaign of three weeks. Ani-
mal capture and restraint equipment were required for all three
campaigns strategies. MSP and DDV + ORV had one equipment
kit for the entire site; in contrast, each CVR team required one
kit. These differences were factored into the costs of each strategy.
2.7. Outcomes
We compared the three alternative dog vaccination strategies in
a rabies endemic setting based on three complementary criteria.
First, we estimated the cost-effectiveness of each strategy as the
cost per dog vaccinated. Second, we compared the vaccination cov-
erage of each vaccination strategy for free-roaming and total dog
population. Third, we estimated the marginal productivity by hour
for each dog vaccination strategy (i.e., vaccination coverage
achieved per hour of operation). Based on the main results from
the analysis, we suggest vaccination strategies under specific con-Table 3
Total vaccination coverage by dog vaccination strategy and evaluation method used.





MSP + CVR 326 502
Peri-urban 112 172
Urban 214 330







MSP + CVR 2590 5332
Peri-urban 856 2220
Urban 1734 3112
DDV + ORV 3300 4213
Peri-urban 1451 2277
Urban 1849 1936
Notes. MSP: mobile static point. CVR: capture, vaccinate, release. DDV: door to door vac
roaming dog population was estimated using a sight-resight survey count survey, basedditions, including target population (free-roaming dogs and total
dog population), and by type of community (peri-urban and urban).
Our goal was to achieve 70% vaccination coverage [1,10,11,40].
2.8. Ethics review
Sample collection activities were covered under CDC IACUC
protocol #2498framulx-a5. All participants, including those taking
blood samples, were members of CVM and MARNDR, and vaccina-
tion and surveillance activities were considered routine job duties.
This evaluation was approved by the CDC’s Human Research Office
(CDC tracking number 062316RW). Since our aim was to evaluate
the implementation of a public health intervention (mass dog vac-
cination), it was considered non-research public health program
evaluation per CDC guidance.
3. Results
3.1. Intervention sites and vaccination coverage
Peri-urban sites ranged in size from 48 km2 to 108 km2 and
urban sites ranged in size from 20.7 km2 to 1.4 km2. The average
across MSP, MSP + CVR, DDV + ORV sites was 76 km2, 128 km2,
and 75 km2, respectively. Population densities across peri-urban
sites ranged from 60 to 135 people/km2 and from 314 to 4643 peo-
ple/ km2 in urban sites. MSP vaccination sites had the largest esti-
mated dog population (n = 5687), followed by MSP + CVR sites
(n = 5331). DDV + ORV sites had the smallest estimated dog popu-
lation (n = 3474) (Table 3). The average proportion of confined
dogs per vaccination site, as determined by combining survey
and SRS, was 32% (n = 1820), 33% (n = 1759), and 41% (n = 1424)
for MSP, MSP + CVR, and DDV + ORV, respectively. The remaining
dogs were classified as free roaming, either individually or
community-owned. Overall, urban sites had more owned-
confined dogs than peri-urban vaccination sites.
A total of 7065 dogs (60.6% of the estimated total dog popula-
tion, 95% CI: 55.3%-67.1%) were vaccinated against rabies during
the vaccination campaign (Table 3). Overall, free-roaming dog vac-
cination coverage, determined by post-vaccination field surveys,
was estimated at 52% (47–56) for MSP, 53% (47–60) for DDV
+ ORV, and 65% (61–69) for MSP + CVR (differences with MSP and



















cination. ORV: oral rabies vaccination. The estimated vaccine coverage for the free-
on the Lincoln-Petersen estimator [36,39].
6168 E.A. Undurraga et al. / Vaccine 38 (2020) 6162–6173roaming dog vaccination coverage for DDV + ORV in urban sites
(34%, 95%CI: 25–45), and the highest free-roaming dog vaccination
coverage for peri-urban communities with MSP + CVR (65%, 95%CI:
58–72) (Table 3). Total dog vaccination coverage was 33% (95%CI:
26–43) for MSP, 49% (95%CI: 40–61) for MSP + CVR and 78% (95%
CI: 77–80) for DDV + ORV (p < 0.001). Vaccination coverage of free
roaming dogs in individual sites ranged from 39% (DDV + ORV) to
88% (MSP + CVR), and for all dogs in individual sites ranged from
31% (MSP) to 94% (DDV + ORV) (Fig. 3). Results for DDV + ORV need
to be interpreted with caution, however, because logistical chal-
lenges in the implementation of the campaign resulted in some
teams running out of oral baits during parts of the day (mostly dur-
ing the last 2hr. of vaccination). We completely ran out of ORV
baits for one DDV + ORV team on the last day of campaign. Consid-
ering that caveat, overall, Fig. 3 and Table 3 suggest MSP + CVR
reached the largest free-roaming dog coverage in peri-urban and
urban sites, and DDV + ORV strategy was the most successful strat-
egy when considering total dog vaccination coverage (Fig. 3).
A total of 590 ORV baits were procured for this evaluation, lim-
iting their use to about 15 baits per team per day. On average,
teams used two ORV baits/hour. A total of 1999 dogs were par-
enterally vaccinated by DDV + ORV teams; an additional 590 dogs
were vaccinated by ORV, 29.5% increase in the number of vacci-
nated dogs due to inclusion of ORV. The vaccination strategy
included both DDV and ORV; if dogs were aggressive or overly
shy, vaccinators used ORV, otherwise, they used a parenteral vac-
cine. About 2% of the dogs offered a bait did not accept it, either
because the dog was not interested or because it was afraid of vac-
cinators. When analyzing hourly use of ORV, over half of vaccina-
tion teams had exhausted the oral vaccine by the fourth hour of
daily operation; suggesting the potential impact of ORV may be
underestimated.Fig. 3. Variation in the effectiveness of dog vaccination strategies across peri-urban and u
CVR: capture vaccinate release; DDV: door-to-door vaccination; ORV: oral rabies vaccine.
roaming dog population that was vaccinated across sites by dog vaccination strategy. (B)
sites by dog vaccination strategy. The figure shows large variations in the effectivenes
approach, even within a department in Haiti.3.2. Costs to vaccinate a dog by vaccination strategy
Table 4 shows a summary of the overall cost per day and the
cost-effectiveness (cost/dog vaccinated) of three alternative strate-
gies. Overall, the least expensive campaign was MSP, with an esti-
mate cost of $2039 per day, and the most expensive was DDV
+ ORV, with a cost of $3246 per day. DDV + ORV was the most
cost-effective of the three strategies considered, with an estimated
cost of $1.97 per dog vaccinated ($2.20 for MSP). The cost per dog
vaccinated in peri-urban communities was higher than in urban
communities for MSP and MSP + CVR, most probably due to the
lower density of dog populations. The cost per dog vaccinated in
peri-urban and urban communities for DDV + ORV was compara-
ble, which reflects the ability to vaccinate dogs that would be
otherwise difficult to reach, thereby increasing the total number
of dogs reached through vaccination efforts.
3.3. Vaccination productivity and efficiency
We found substantial variation in the average number of dogs
vaccinated per staff member per day of campaign operation (vacci-
nator efficiency). The MSP + CVR was the least efficient strategy,
ranging from 12.6 to 20.1 dogs vaccinated per staff member per
day. The most efficient strategy was DDV + ORV, which had effi-
ciency rates ranging from 26.6 to 39.0 dogs vaccinated per staff
member per day.
We used OLS regressions to provide a systematic way of mea-
suring productivity measured as (A) the number of dogs vaccinated
per hour by strategy (strategy productivity) and (B) as the number
of dogs vaccinated per vaccinator per hour (vaccinator productiv-
ity). We used regression results (supplementary material), to char-
acterize the relation between time and strategy productivity andrban study sites in Croix-des-Bouquets, Haiti, 2016. Notes.MSP: mobile static point;
The subscript f denotes free-roaming dogs. (A) Distribution in the proportion of free-
Distribution of the proportion of the total dog population that was vaccinated across
s of dog vaccinations. These results underscore that there is no ‘‘one-size-fits-all”
Table 4
Main daily outcomes of the evaluation of three alternative strategies for mass dog
vaccination, West Department, Haiti 2016: (i) Mobile static point vaccination (MSP),
(ii) MSP + Capture, vaccinate, and release (CVR), (iii) Door-to-door (DDV) + Oral rabies
(ORV).
Vaccination strategy Urban Peri-urban Total
Intervention
Sites 9 6 15
Average costs of the intervention*
Shared costs (by sector)
Awareness campaigns $360 $240 $600
Mobile Static Point (MSP)
Vaccines $655 $414 $1069
Human resources $910 $607 $1517
Transport $374 $250 $624
Equipment / supplies $161 $107 $268
Sub-total costs MSP $2,460 $1,618 $4078
MSP + Capture, vaccinate, release (CVR)
Vaccines $1,000 $494 $1493
Human resources $1,378 $919 $2297
Transport $655 $437 $1092
Equipment / supplies $261 $174 $435
Sub-total costs MSP + CVR $3,654 $2,263 $5917
Door to Door (DDV) + Oral rabies (ORV)
Vaccines $1,587 $1,480 $3067
Human resources $1,066 $711 $1777
Transport $468 $312 $780
Equipment / supplies $161 $107 $268
Sub-total costs DDV + ORV $3,642 $2,850 $6492
Cost-per dog vaccinated
Cost per dog vaccinated MSP $2.17 $2.25 $2.20
Cost per dog vaccinated MSP + CVR $2.11 $2.64 $2.28
Cost per dog vaccinated DDV + ORV $1.97 $1.96 $1.97
Notes. * Costs correspond to the average by vaccination strategy of two days of work
in each study site. Please note some sums do not exactly add up due to rounding of
cents.
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for the number of dogs vaccinated/hour, for all strategies com-
bined, MSP, MSP + CVR, and DDV + ORV. Recall that the number
of vaccinators in each vaccination strategy was different, so Fig. 4
should be interpreted with caution. Fig. 5 in contrast, shows the
rate of vaccinated dogs per hour per vaccinator, for all sites, and
for each vaccination strategy. Two results stand out. First, MSP
+ CVR (Fig. 5, panel C) showed less average productivity, but had
a more stable productivity during the day than the other strategies.
The larger negative slope of the productivity curve for MSP (Fig. 5,
panel B), suggests that the addition of CVR to the MSP strategy
helped maintain a more constant productivity rate. Second, DDV
+ ORV proved to be, on average, the most productive strategy
throughout the day (albeit with larger confidence intervals).
We last examined trends in dog vaccination coverage, for each
vaccination strategy implemented. Fig. 6 shows estimated cover-
age rates by hour (i.e., number of dogs vaccinated at hour ‘‘t”/total
dog population), and trends were estimated using locally weighted
scatter plot smoothing (LOWESS). Results suggest that MSP and
MSP + CVR, in the conditions that our vaccination program was
implemented in Haiti, would not be enough to achieve 70% vacci-
nation or would require additional resources. In contrast, DDV
+ ORV tended to reach the expected target, most likely because
the strategy provides a means to access hard-to-reach, aggressive,
or fearful dogs that otherwise would not have been vaccinated.4. Discussion
We assessed the costs, effectiveness, and cost-effectiveness out-
comes for three mass dog vaccination strategies, MSP, MSP + CVR,
and DDV + ORV, in urban and peri-urban sections of Croix-des-
Bouquets (2016). DDV + ORV was the most successful strategywhen considering vaccination coverage for all dog population.
MSP + CVR was the most effective strategy to reach free-roaming
dogs, probably because some teams ran out of baits during parts
of the day. The least expensive campaign was MSP, with an esti-
mate cost of about $2039 per day of operation, and the most
expensive was DDV + ORV, with a cost of $3246 per day. However,
DDV + ORV was the most cost-effective vaccination strategy and
MSP did not achieve the desired coverage in any of the sites. We
also saw a substantial decrease in dogs vaccinated per vaccinator
per hour throughout the day across all strategies. Our results sug-
gest MSP and MSP + CVR may not be enough to achieve the goal of
70% of the dog population vaccinated or would require substantial
additional efforts to reach this objective. The goal of dog vaccina-
tion programs is to reach a level of herd immunity to cease enzoo-
tic transmission of the virus; practical experience has shown this is
achieved with  70% vaccination coverage among the susceptible
dogs in most settings [1,10,11]. Vaccination coverage for all dogs
nearly doubled when DDV was used in lieu of MSP.
Dog population estimation is important for planning and evalu-
ating vaccinations campaigns, but estimation methods are time
consuming, costly, and prone to measurement error. Our estimated
dog vaccination coverage reflects these limitations showing wide
confidence intervals. Estimated dog population always included
confined dogs. In theory, confined dogs are not necessarily suscep-
tible to rabies infection, as they may not interact with susceptible
dogs and thus could have only a limited or null role in viral trans-
mission. In Haiti community members’ interpretations of a ‘‘con-
fined dog” may have included dogs that occasionally roam or
remain in the yard where community dogs have access to. Field
teams suggested that even self-reported confined dogs had some
risk of interaction with susceptible free-roaming dogs. Because
the share of confined dogs varies between communities, our esti-
mates of dog vaccination coverage from SRS surveys are possibly
better indicators of campaign success than estimates of immunity
among susceptible dog populations.
When vaccinating a relatively low number of dogs, the fixed
costs of a vaccination campaign are relatively high. However, as
the number of vaccinated dogs increase, the average cost per dog
vaccinated decreases. This fact may partially explain the wide
range of costs to vaccinate a dog reported in the literature, partic-
ularly those ‘‘sweet spot” estimates for vaccinations in the range of
30–50% of the dog population [40]. A large proportion of dog vac-
cination campaign costs correspond to human resources, mostly
vaccination staff [23,31,41–43]. Therefore, increasing the number
of dogs vaccinated per day for a team can have a large impact on
reducing overall program costs. Campaign costs should consider
the end-coverage achieved and the efficiency of the vaccinators
conducting the program to better evaluate if the strategy was
successful.
When considering efficiency, costs, vaccination coverage, and
vaccinators’ productivity, no single strategy was clearly favorable
in all conditions or across all sites, even within a department in
Haiti. Our results for Haiti suggest that in peri-urban settings the
DDV + ORVmethod would be the most successful to maximize vac-
cination coverage levels. In urban settings, a combination of meth-
ods may be required; a potentially successful combination of
methods may include MSP for several hours, followed by two or
more days of DDV + ORV or CVR to ensure free roaming dogs are
adequately vaccinated. A study in India [44] described the strategy
of vaccination-assessment-move, in which the number and distri-
bution of dog vaccinations is tracked in near-real-time, and deci-
sions on completeness of a vaccination site are based on
feedback from field operators and geo-spatial evaluation. This
method does not limit the number of days in a vaccination site
to an a priori protocol decision; the duration is based on field infor-
mation. If applied in Haiti, this strategy may improve coverage,
Fig. 4. Predicted results from OLS regressions of the number of dogs vaccinated by hour, for (A) all vaccination strategies combined, (B) mobile static point (MSP), (C), MSP
+ capture vaccinate release (CVR), and (D) door-to-door vaccination (DDV) and oral rabies vaccine (ORV). Notes. Predicted values of the number of dogs vaccinated by hour
obtained from OLS regressions (supplementary material, Table S1). Sample size = 60. MSP stands for Mobile Static Point. CVR stands for Capture Vaccinate Release. ORV stands
for Oral Rabies Vaccination. DDV stands for Door to Door Vaccination (see Supplementary material for specific coefficients and equations).
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methods (MSP + CVR and DDV + ORV).
In August 2016 a rabies outbreak was detected in Croix-des-
Bouquets commune, West Department, through Haiti’s national
rabies surveillance program [22] after seven dog rabies cases were
confirmed in the preceding six months. During the six months fol-
lowing this emergency vaccination program there were no further
human rabies cases in the study area, but an additional four dog
rabies cases were reported. While rabies cases declined, the cam-
paign did not halt transmission. Synthesis of these results, and
reformulation of the national vaccination strategy may help
develop more cost-effective approaches to national dog vaccina-
tion in Haiti, and increased probability of complying with OIE/
WHO dog vaccination guidance.
Of the three vaccination strategies used, DDV + ORV resulted in
the lowest costs per dog vaccinated ($1.97). Despite the relatively
higher costs of ORV compared to parenteral vaccines, ORV allowed
vaccinators to more rapidly vaccinate dogs that were not readily
accessible due to aggressive or shy behavior. MSP was a relatively
costly vaccination strategy, on average, when considering cost per
dog vaccinated ($2.20). MSP operations showed high vaccination
productivity during the first two hours of operation; but the mar-
ginal productivity of vaccinators decreased substantially during
the day, resulting in higher overall costs compared to other strate-
gies. In contrast, hourly productivity for DDV + ORV and MSP + CVR
were more uniformly distributed along the day, and DDV + ORV
showed consistent high productivity throughout the day (Figs. 4
and 5). MSP typically attracts motivated owners with controllable
dogs [13]; when this subpopulation reaches saturation the cam-
paign decreases efficiency.Many lessons and practices that were successful in the elimina-
tion of dog rabies in Latin America and the Caribbean (LAC) [28]
may be applicable to Haiti. But conditions in Haiti suggest that
novel strategies of rabies control, which require a more skilled
workforce, need to be assessed to achieve the goal of zero dog-
rabies-mediated human deaths by 2030 [23]. MSP vaccination
strategies in Haiti have not resulted in vaccination coverage
required for rabies elimination. Considering commonly used indi-
cators of human development, education, economic growth, and
health, Haiti is similar to rabies endemic countries in Sub-
Saharan Africa. To illustrate, in 2015, Haiti had a sociodemographic
index (SDI) [45], an index combining income, health, and education
used by the Global Burden of Disease studies, of 0.401, comparable
to 0.391 for Sub-Saharan Africa (SSA) and substantially lower than
0.678 for LAC. Human Development Index for Haiti is 0.493, com-
parable to 0.523 in SSA and much lower than 0.751 for LAC. About
38% of the population has access to electricity in Haiti, compared to
43% in SSA and 98% in LAC [46] (further comparisons in supple-
mentary material). Considering rabies epidemiology, logistical
challenges, and resource limitations, lessons learned in Haiti may
be more relevant to low-income countries with endemic dog-
transmitted human rabies, such as those in SSA, than to countries
with sporadic or controlled [47] dog transmitted rabies.
Our evaluation is not without limitations. First, the dog vaccina-
tion strategies assessed were implemented in five sections of
Croix-des-Bouquets Commune of the West Department, Haiti.
We found substantial variability in the effectiveness of vaccination
in the evaluation sites, and they may not necessarily be represen-
tative of all Haiti or other countries. We partially addressed this
limitation by randomly assigning each vaccination strategy to sec-
Fig. 5. Predicted results from OLS regressions of the number of dogs vaccinated by vaccinator per hour, for (A) all vaccination strategies combined, (B) mobile static point
(MSP), (C), MSP + capture vaccinate release (CVR), and (D) door-to-door vaccination (DDV) and oral rabies vaccine (ORV). Notes. Predicted values of the number of dogs
vaccinated per vaccinator per hour obtained from OLS regressions (Supplementary material, Table S1). Sample size = 60. MSP stands for Mobile Static Point. CVR stands for
Capture Vaccinate Release. ORV stands for Oral Rabies Vaccination. DDV stands for Door to Door Vaccination. (see Supplementary material for specific coefficients and
equations).
Fig. 6. Estimated coverage rates for dog vaccination by mass vaccination strategy
for the total dog population. Notes. Coverage rates are calculated as total number of
dogs vaccinated at hour ‘‘t” / total dog population. trends were estimated using
locally weighted scatterplot smoothing (LOWESS). MSP stands for Mobile Static
Point. CVR stands for Capture Vaccinate Release. ORV stands for Oral Rabies
Vaccination. DDV stands for Door to Door Vaccination.
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varies by a wide range of factors, including distance and topogra-
phy, dog density, dog owner reception to vaccination, vaccinator
experience, trust in government officials, dog ownership practices,
public infrastructure [13,41,48,49]; our results need to be inter-
preted accordingly. Second, the project was implemented in theWest Department and carried out by workers from the government
of Haiti in collaboration with international partners. Implementing
the program at the national level may not necessarily lead to the
same results, due to differences in trained vaccinators, public
infrastructure, and dog population, among other characteristics.
For example, our estimated costs per dog vaccinated were less
expensive (in 2016 dollars) than estimates in other rabies-
endemic countries, such as Indonesia (US$2.63) [50] or Chad
(US$2.40) [49], probably because of implementation in a limited
geographical area.
Third, there are field challenges that could affect dog vaccina-
tion coverage, including dog ownership practices, trust in the gov-
ernment, accessibility, availability of vaccinators, cold chains, and
even specific features of the vaccination campaign. For instance,
we piloted several alternatives of coating for ORV vaccines, some
of which had much lower uptake than boiled pig intestines. We
also had a relatively limited procurement of ORV baits, which lim-
ited the ability of some vaccination teams to use them when
needed; results of the DDV + ORV likely represent the lowest
expected coverage by this strategy and could probably have been
higher had ample ORV been made available, as found elsewhere
[51]. Daily vaccination data also showed that rabies vaccination
teams used substantially less ORV baits during the first day of vac-
cination, probably because of vaccinators’ lack of experience with
ORV, and during the last three days of vaccination, due to dwin-
dling ORV bait supplies and rationing of ORV allocated to the teams
by vaccination programmanagers. Last, no ORV dog received a col-
lar and the use of paint sprayed from a syringe may have not been
as visible as collar and wax, which may have resulted in an under-
estimate of vaccinated ORV dogs.
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Our results suggest that strategies beyond MSP can be poten-
tially cost-effective, depending on implementation settings. DDV
+ ORV seemed to give the best overall vaccination coverage results
in our study. Unfortunately, ORV is not currently readily available
or a common tool in the design and implementation of dog vacci-
nation campaigns, and may require some extra labor to make baits.
Recently, Smith et al. [37] showed that the ORV construct used in
this vaccination campaign was highly effective at vaccinating inac-
cessible dogs in Haiti, with seroconversion rates of 59–78%. Despite
the relative high cost of an ORV bait (more than four times the
costs of a parenteral vaccination), combining DDV and ORV was
the most cost-effective strategy in our comparison, largely due to
increased efficiency of the vaccinators. MSP was an effective strat-
egy during the first hours of operation, but marginal productivity
of vaccinators declined during the day. In contrast, DDV + ORV
maintained high productivity throughout the day. Hourly produc-
tivity for MSP + CVR and DDV + ORV were more uniformly dis-
tributed. Combining various vaccination strategies is probably
required to achieve the goal of 70% vaccination. We hope the
results from this study will support the design and implementation
of more effective dog vaccination campaigns to achieve the goal of
dog-mediated human rabies elimination by 2030 [23,52].6. Financial support
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